Position
Fidelity in Caris Life Sciences, Inc.
Back to the book · All holders of CAI
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.85M$17.88 → $17.82
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 14.2M | $383.6M | — | — | — | 0.0% |
| Q1 2026 | 30.8M | $550.4M | $17.88 | −$129.4M | $296.2M | 0.0% |
| Q2 2026 | 30.9M | $551.1M | $17.82 | −$1.85M | $2.46M | 0.0% |